ALD-话题@MedSci

#ALD#

59篇内容 | 2180人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1469418, encodeId=92f91469418c6, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Cell Death Dis：ALDOA通过Oct4/DUSP4/TRAF4通路诱导肺癌细胞获得干细胞特性, objectType=article, longId=191378, objectId=dcb51913e865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcb51913e865, replyNumber=0, likeNumber=40, createdTime=2020-04-05, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcb51913e865, moduleTitle=Cell Death Dis：ALDOA通过Oct4/DUSP4/TRAF4通路诱导肺癌细胞获得干细胞特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcb51913e865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469417, encodeId=c726146941e59, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症, objectType=article, longId=185329, objectId=0ab6185329f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ab6185329f3, replyNumber=0, likeNumber=75, createdTime=2019-12-29, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ab6185329f3, moduleTitle=Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ab6185329f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469416, encodeId=7c4c146941604, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价, objectType=article, longId=184068, objectId=8836184068ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8836184068ed, replyNumber=0, likeNumber=65, createdTime=2019-12-04, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8836184068ed, moduleTitle=Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8836184068ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469415, encodeId=02b8146941529, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, objectType=article, longId=181586, objectId=ec6318158639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec6318158639, replyNumber=0, likeNumber=76, createdTime=2019-10-21, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec6318158639, moduleTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec6318158639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469414, encodeId=5909146941422, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=GlobalData全新预测，女性不育药物市场2028年将增至25亿美元, objectType=article, longId=181546, objectId=36241815464c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36241815464c, replyNumber=0, likeNumber=0, createdTime=2019-10-20, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36241815464c, moduleTitle=GlobalData全新预测，女性不育药物市场2028年将增至25亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36241815464c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469413, encodeId=20a2146941303, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Galderma的新型类维生素A乳膏获得FDA批准，用于痤疮的局部治疗, objectType=article, longId=180539, objectId=0783180539fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0783180539fc, replyNumber=0, likeNumber=75, createdTime=2019-10-07, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0783180539fc, moduleTitle=Galderma的新型类维生素A乳膏获得FDA批准，用于痤疮的局部治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0783180539fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469412, encodeId=d8d114694124a, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, objectType=article, longId=179627, objectId=a28c1e962734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a28c1e962734, replyNumber=0, likeNumber=37, createdTime=2019-09-19, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a28c1e962734, moduleTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a28c1e962734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469411, encodeId=c6f1146941191, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来, objectType=article, longId=177269, objectId=c6c41e72691e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c41e72691e, replyNumber=0, likeNumber=81, createdTime=2019-08-10, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c41e72691e, moduleTitle=Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6c41e72691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469410, encodeId=becc146941004, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=FDA授予OTL-103再生医学高级治疗（RMAT）认定用于治疗Wiskott-Aldrich综合征, objectType=article, longId=176838, objectId=82c81e6838d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82c81e6838d9, replyNumber=0, likeNumber=63, createdTime=2019-08-06, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c81e6838d9, moduleTitle=FDA授予OTL-103再生医学高级治疗（RMAT）认定用于治疗Wiskott-Aldrich综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c81e6838d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469409, encodeId=3e771469409fe, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=NEJM：Tornwaldt囊肿-病例报道, objectType=article, longId=166192, objectId=2f3316619291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f3316619291, replyNumber=0, likeNumber=73, createdTime=2019-05-17, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f3316619291, moduleTitle=NEJM：Tornwaldt囊肿-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f3316619291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469408, encodeId=308c146940861, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估, objectType=article, longId=164438, objectId=87fe1644385f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87fe1644385f, replyNumber=0, likeNumber=36, createdTime=2019-04-18, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87fe1644385f, moduleTitle=Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87fe1644385f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469407, encodeId=76da146940e2f, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=J Clin Invest：揭示USP9X去泛素化ALDH1A3并维持GCSs的间充质特性, objectType=article, longId=164088, objectId=108d16408858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=108d16408858, replyNumber=0, likeNumber=63, createdTime=2019-04-13, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=108d16408858, moduleTitle=J Clin Invest：揭示USP9X去泛素化ALDH1A3并维持GCSs的间充质特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=108d16408858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469406, encodeId=126b146940664, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Galderma：新数据显示口服和局部联合治疗严重丘疹脓疱性红斑痤疮患者的临床益处, objectType=article, longId=161547, objectId=a8ea16154e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8ea16154e26, replyNumber=0, likeNumber=61, createdTime=2019-03-04, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8ea16154e26, moduleTitle=Galderma：新数据显示口服和局部联合治疗严重丘疹脓疱性红斑痤疮患者的临床益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8ea16154e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469405, encodeId=36851469405af, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Opdivo与bempegaldesleukin联合用于一线治疗尿路上皮癌的结果令人满意, objectType=article, longId=160531, objectId=d64716053136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64716053136, replyNumber=0, likeNumber=53, createdTime=2019-02-21, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64716053136, moduleTitle=Opdivo与bempegaldesleukin联合用于一线治疗尿路上皮癌的结果令人满意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64716053136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469404, encodeId=70721469404c1, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力, objectType=article, longId=159490, objectId=6d4b159490e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4b159490e2, replyNumber=0, likeNumber=76, createdTime=2019-02-05, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4b159490e2, moduleTitle=J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4b159490e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469403, encodeId=a44014694030b, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Alder Bio制药报告了Eptinezumab慢性偏头痛的的新近进展, objectType=article, longId=142039, objectId=7e6214203922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6214203922, replyNumber=0, likeNumber=97, createdTime=2018-07-02, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6214203922, moduleTitle=Alder Bio制药报告了Eptinezumab慢性偏头痛的的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e6214203922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469402, encodeId=48f614694022e, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Stem cells：沉默Aldefluor+ 乳腺CSCs的TAP1的表达有助于肿瘤细胞免疫逃逸, objectType=article, longId=128566, objectId=03e312856641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e312856641, replyNumber=0, likeNumber=65, createdTime=2018-02-03, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e312856641, moduleTitle=Stem cells：沉默Aldefluor+ 乳腺CSCs的TAP1的表达有助于肿瘤细胞免疫逃逸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e312856641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469401, encodeId=dbc0146940146, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=多发性硬化的诊断：2017版McDonald标准, objectType=article, longId=126169, objectId=61d712616999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61d712616999, replyNumber=0, likeNumber=38, createdTime=2018-01-12, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61d712616999, moduleTitle=多发性硬化的诊断：2017版McDonald标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61d712616999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469400, encodeId=63611469400bf, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Lancet Neurol：临床孤立综合征患者多发性硬化诊断预测标准研究——2016 MAGNIMS vs2010 McDonald, objectType=article, longId=124551, objectId=d1c1124551a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c1124551a1, replyNumber=0, likeNumber=51, createdTime=2017-12-27, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c1124551a1, moduleTitle=Lancet Neurol：临床孤立综合征患者多发性硬化诊断预测标准研究——2016 MAGNIMS vs2010 McDonald, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c1124551a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1469399, encodeId=11081469399c1, content=<a href='/topic/show?id=9d6522e613' target=_blank style='color:#2F92EE;'>#ALD#</a>, objectTitle=Autophagy：ALDH1A1和HLTF调节溶酶体自噬抑制剂活性的作用在哪些癌症中具有较好的效果？, objectType=article, longId=116110, objectId=f9141161108b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9141161108b, replyNumber=0, likeNumber=90, createdTime=2017-10-15, rootId=0, userName=zhangjingnwpu, userId=64f67025397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9141161108b, moduleTitle=Autophagy：ALDH1A1和HLTF调节溶酶体自噬抑制剂活性的作用在哪些癌症中具有较好的效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9141161108b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ALD

2020-05-29

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Cell Death Dis：ALDOA通过Oct4/DUSP4/TRAF4通路诱导肺癌细胞获得干细胞特性

2020-04-05

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Lancet Haemat：acalabrutinib治疗Waldenström巨球蛋白血症

2019-12-29

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价

2019-12-04

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链

2019-10-21

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

GlobalData全新预测，女性不育药物市场2028年将增至25亿美元

2019-10-20

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Galderma的新型类维生素A乳膏获得FDA批准，用于痤疮的局部治疗

2019-10-07

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利

2019-09-19

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来

2019-08-10

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

FDA授予OTL-103再生医学高级治疗（RMAT）认定用于治疗Wiskott-Aldrich综合征

2019-08-06

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

NEJM：Tornwaldt囊肿-病例报道

2019-05-17

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Lancet haemat：慢病毒造血干细胞基因编辑疗法用于Wiskott-Aldrich综合征患儿的临床疗效和安全性评估

2019-04-18

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

J Clin Invest：揭示USP9X去泛素化ALDH1A3并维持GCSs的间充质特性

2019-04-13

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Galderma：新数据显示口服和局部联合治疗严重丘疹脓疱性红斑痤疮患者的临床益处

2019-03-04

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Opdivo与bempegaldesleukin联合用于一线治疗尿路上皮癌的结果令人满意

2019-02-21

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力

2019-02-05

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Alder Bio制药报告了Eptinezumab慢性偏头痛的的新近进展

2018-07-02

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Stem cells：沉默Aldefluor+ 乳腺CSCs的TAP1的表达有助于肿瘤细胞免疫逃逸

2018-02-03

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

多发性硬化的诊断：2017版McDonald标准

2018-01-12

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Lancet Neurol：临床孤立综合征患者多发性硬化诊断预测标准研究——2016 MAGNIMS vs2010 McDonald

2017-12-27

zhangjingnwpu (审核中...)

前往app查看评论内容

#ALD#

Autophagy：ALDH1A1和HLTF调节溶酶体自噬抑制剂活性的作用在哪些癌症中具有较好的效果？

2017-10-15

科室
- - 订阅+
  - 更多科室
工具
服务